World Investment Advisors Purchases Shares of 41,326 Columbia Research Enhanced Value ETF $REVS

World Investment Advisors purchased a new stake in shares of Columbia Research Enhanced Value ETF (NYSEARCA:REVSFree Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 41,326 shares of the company’s stock, valued at approximately $1,169,000. World Investment Advisors owned approximately 0.64% of Columbia Research Enhanced Value ETF as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Essex Financial Services Inc. lifted its position in shares of Columbia Research Enhanced Value ETF by 46.1% during the 3rd quarter. Essex Financial Services Inc. now owns 11,811 shares of the company’s stock valued at $330,000 after acquiring an additional 3,725 shares during the last quarter. Private Advisor Group LLC acquired a new stake in shares of Columbia Research Enhanced Value ETF during the 3rd quarter valued at $448,000. Wealth Enhancement Advisory Services LLC lifted its position in shares of Columbia Research Enhanced Value ETF by 11.2% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 100,569 shares of the company’s stock valued at $2,817,000 after acquiring an additional 10,095 shares during the last quarter. NewEdge Advisors LLC lifted its position in shares of Columbia Research Enhanced Value ETF by 13.4% during the 2nd quarter. NewEdge Advisors LLC now owns 122,687 shares of the company’s stock valued at $3,224,000 after acquiring an additional 14,498 shares during the last quarter. Finally, U.S. Capital Wealth Advisors LLC acquired a new stake in shares of Columbia Research Enhanced Value ETF during the 4th quarter valued at $3,446,000.

Columbia Research Enhanced Value ETF Stock Performance

Shares of NYSEARCA:REVS opened at $30.76 on Monday. Columbia Research Enhanced Value ETF has a one year low of $24.92 and a one year high of $31.18. The stock has a fifty day moving average of $29.49 and a 200-day moving average of $29.07. The company has a market capitalization of $282.99 million, a PE ratio of 16.41 and a beta of 0.80.

Columbia Research Enhanced Value ETF Profile

(Free Report)

The Columbia Research Enhanced Value ETF (REVS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000 Value Index. REVS index uses multifactor selection and market cap weighting. REVS was launched on Sep 25, 2019 and is managed by Columbia.

Further Reading

Institutional Ownership by Quarter for Columbia Research Enhanced Value ETF (NYSEARCA:REVS)

Receive News & Ratings for Columbia Research Enhanced Value ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Columbia Research Enhanced Value ETF and related companies with MarketBeat.com's FREE daily email newsletter.